Previous close | 2.3000 |
Open | 2.2500 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 230.00 |
Expiry date | 2024-06-21 |
Day's range | 2.2500 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 126 |
On CRISPR Therapeutics' (CRSP) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to the first sales numbers of its newly approved gene therapy, Casgevy.
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has come a long way since the turn of the millennium more […]
On May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) as reported in a recent SEC Filing.